head_banner

News

News

  • Entecavir Monohydrate CAS 209216-23-9 USP43-NF38

    Entecavir C12H15N5O3·H2O 295.29 6H-Purin-6-one, 2-amino-1,9-dihydro-9-[(1S,3R,4S)-4-hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]-, monohydrate; 9-[(1S,3R,4S)-4-Hydroxy-3-(hydroxymethyl)-2-methylenecyclopentyl]guanine monohydrate [209216-23-9]; UNII: 5968Y6H45M. Anhydrous 277.28 DEFINITION E...
    Read more
  • Candesartan Cilexetil CAS 145040-37-5 – European Pharmacopoeia 11.0

    CANDESARTAN CILEXETIL Candesartanum cilexetili C33H34N6O6 Mr 611 [145040-37-5] DEFINITION (1RS)-1-[[(Cyclohexyloxy)carbonyl]oxy]ethyl 2-ethoxy-1-[[2′-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-benzimidazole-7-carboxylate. Content: 99.0 per cent to 101.0 per cent (anhydrous substance). PRODUCTION ...
    Read more
  • Irbesartan CAS 138402-11-6 – USP43-NF38

    Irbesartan C25H28N6O 428.53 1,3-Diazaspiro[4.4]non-1-en-4-one, 2-butyl-3-[[2′-(1H-tetrazol-5-yl)[1,1′-biphenyl]-4-yl]methyl]-; 2-Butyl-3-[p-(o-1H-tetrazol-5-ylphenyl)benzyl]-1,3-diazaspiro[4.4]non-1-en-4-one [138402-11-6]; UNII: J0E2756Z7N. DEFINITION Irbesartan contains NLT 98.0% and NMT 102.0% ...
    Read more
  • Telmisartan CAS 144701-48-4 European Pharmacopoeia 11.0

    Telmisartan CAS 144701-48-4 European Pharmacopoeia 11.0 C33H30N4O2 Mr 514.6 [144701-48-4] DEFINITION 4′-[[4-Methyl-6-(1-methyl-1H-benzimidazol-2-yl)-2-propyl-1H-benzimidazol-1-yl]methyl][1,1′-biphenyl]-2-carboxylic acid. Content: 99.0 per cent to 101.0 per cent (dried substance). CHARACTER...
    Read more
  • Sodium Salicylate CAS 54-21-7 USP35 Standard

    Sodium Salicylate C7H5NaO3 160.10 Benzoic acid, 2-hydroxy-, monosodium salt; Monosodium salicylate [54-21-7]; UNII: WIQ1H85SYP. DEFINITION Sodium Salicylate contains NLT 98.0% and NMT 102.0% of sodium salicylate (C7H5NaO3), calculated on the anhydrous basis. IDENTIFICATION Change to read: • A. S...
    Read more
  • Sodium Salicylate CAS 54-21-7 EP11.0 Standard

    SODIUM SALICYLATE Natrii salicylas C7H5NaO3 Mr 160.1 [54-21-7] DEFINITION Sodium 2-hydroxybenzenecarboxylate. Content: 99.0 per cent to 101.0 per cent (dried substance). CHARACTERS Appearance: white or almost white, crystalline powder or small, colourless crystals or shiny flakes. Solub...
    Read more
  • Aripiprazole CAS 129722-12-9 USP43-NF38

    Aripiprazole C23H27Cl2N3O2 448.39 2(1H)-Quinolinone, 7-[4-[4-(2,3-dichlorophenyl)-1- piperazinyl]butoxy]-3,4-dihydro-; 7-[4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butoxy]-3,4-dihydrocarbostyril [129722-12-9]; UNII: 82VFR53I78. DEFINITION Aripiprazole contains NLT 98.0% and NMT 102.0% of aripiprazo...
    Read more
  • 5-Fluorouracil (5-FU) CAS 51-21-8 USP43 Standard

    Fluorouracil C4H3FN2O2 130.08 2,4(1H,3H)-Pyrimidinedione, 5-fluoro-; 5-Fluorouracil [51-21-8]; UNII: U3P01618RT. DEFINITION Fluorouracil contains NLT 98.0% and NMT 102.0% of uorouracil (C4H3FN2O2), calculated on the dried basis. [ CAUTION- Great care should be taken to prevent inhaling particles ...
    Read more
  • Method Of Analyzing Palladium Content In Palladium Catalysts

    1. Abstract Enrichment palladium of palladium catalysts by pyrometallurgy, then dissolve the palladium in admixture acid, the liquid is analyzed by AAS. 2. Reagent 2.1 Hydrochloric acid(ρ1.19g/ml) 2.2 Nitric acid(ρ1.42g/ml) 2.3 Admixture acid (Hydrochloric acid and Nitric acid mixed,volume as 3:1...
    Read more
  • New COVID treatments offer hope

    New COVID treatments offer hope

    Scientists around the world have made promising breakthroughs in developing a cure for COVID-19. Among new developments include antiviral pills and antibody compounds. As more countries look to adopt these treatments, let’s examine the pros and cons of each remedy, and how they could affect...
    Read more
  • The third Guangdong-Hong Kong-Macao Greater Bay Area Pharmaceutical Innovation Technology and Market Access Summit forum November 19 to 21, 2021

    The third Guangdong-Hong Kong-Macao Greater Bay Area Pharmaceutical Innovation Technology and Market Access Summit forum November 19 to 21, 2021

    The third Guangdong-Hong Kong-Macao Greater Bay Area Pharmaceutical Innovation Technology and Market Access Summit forum November 19 to 21, 2021 As the world’s second largest medical market, China’s big health industry is ushering in a golden decade. Facing the super aging society in ...
    Read more
  • Xi presents award to top scientists

    Xi presents award to top scientists

    President Xi Jinping, also general secretary of the Communist Party of China (CPC) Central Committee and chairman of the Central Military Commission, presents China’s top science award to aircraft designer Gu Songfen (R) and nuclear expert Wang Dazhong (L) at an annual ceremony to honor d...
    Read more
  • Paxlovid: what we know about Pfizer’s Covid-19 pill

    Paxlovid: what we know about Pfizer’s Covid-19 pill

    Pfizer is seeking emergency use authorisation from the FDA for its novel Covid-19 antiviral pill Paxlovid. Share Article On the heels of Merck antiviral molnupiravir’s UK approval, Pfizer has set out to get its own Covid-19 pill, Paxlovid, on the market. This week, the US drugmaker soug...
    Read more
  • Pfizer’s Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

    Pfizer’s Novel COVID-19 Oral Antiviral Treatment Candidate Reduced Risk Of Hospitalization Or Death By 89% In Interim Analysis Of Phase 2/3 EPIC-HR Study

    Friday, November 05, 2021 – 06:45am PAXLOVID™ (PF-07321332; ritonavir) was found to reduce the risk of hospitalization or death by 89% compared to placebo in non-hospitalized high-risk adults with COVID-19 In the overall study population through Day 28, no deaths were reported in patients...
    Read more
12 Next > >> Page 1 / 2